Drawing for REFLECTIONBIO

USPTO serial 88091965

REFLECTIONBIO

Reviewed by CopyMark Law Group

Reg. 5888417Status 710
Filing date
Status date
Registration date
Oct 22, 2019
Examiner
DANTZLER, LAUREN ALEXANDRIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with REFLECTIONBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kerrijane John

Kerrijane John Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medical and veterinary preparations for genetically based diseases and rare disorders; sanitary preparations for medical purposes; dietetic food and substances, in the nature of sugar adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; medicines for human purposes for the treatment of genetically based diseases and rare disorders; pharmaceuticals for genetically based diseases and rare disorders; pharmaceutical preparations for use in the treatment of genetically based diseases and rare disorders; pharmaceutical preparations for gene therapy and cell therapySECTION 8 - CANCELLED—
042Scientific and technological services and research and design in the fields of genetically based diseases and rare disorders, orphan drugs, gene therapy, and cell therapy; industrial analysis and research services in the fields of genetically based diseases and rare disorders, orphan drugs, gene therapy, and cell therapy; design and development of computer hardware and software; scientific and medical research and development; research and development of orphan drugsSECTION 8 - CANCELLED—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; agricultural services, namely, compost spreading; forestry services, namely, insecticide spraying for forestry; health and medical counselling; providing health care and medical information; providing a website featuring educational information regarding rare diseases, orphan drugs, gene therapy, cell therapy and other treatment options; Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advisory and information services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; Health care advisory and information services for patients and their families regarding the coordination of medical services; Advice and consultation services, namely, providing advice, information and assistance to patients and their families in dealing with medical service providers, hospitals, insurance companies, and others involved in patient careSECTION 8 - CANCELLED—
045Personal and social services rendered by others to meet the needs of individuals, namely, providing patient advocacy services regarding the coordination and combination of efforts by patients and families in driving scientific and medical research and development; providing patient advocacy services in the field of gene therapy and cell therapy; providing case management services, namely, coordinating patient and family health care medical services; health care advocacy services for patients and their families regarding the coordination of medical services; health care case management services, namely, medical care coordination for patients and familiesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 8, 2026C8..CANCELLED SEC. 8 (6-YR)—
Oct 22, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 22, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 21, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 21, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 6, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 6, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 17, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 26, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 15, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2019ALIEASSIGNED TO LIE—
Jun 11, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 12, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2018DOCKASSIGNED TO EXAMINER—
Sep 4, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance